Indivior Pharmaceuticals, Inc. Common Stock (INDV) is a publicly traded Healthcare sector company. As of August 24, 2026, INDV trades at $35.49 with a market cap of $4.35B and a P/E ratio of 12.45. INDV moved -3.58% today. Year to date, INDV is +2.76%; over the trailing twelve months it is +53.31%. Its 52-week range spans $7.62 to $42.81. Analyst consensus is strong buy with an average price target of $48.00. Rallies surfaces INDV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for INDV, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $35.49 |
| Market Cap | $4.35B |
| P/E Ratio | 12.45 |
| EPS | $2.88 |
| Dividend Yield | 0.00% |
| 52-Week High | $42.81 |
| 52-Week Low | $7.62 |
| Volume | 971.83K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.33B |
| Net Income | $355.00M |
| Gross Margin | 81.98% |
3 analysts cover INDV: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $48.00.